Package 70518-4100-3

{"route": ["ORAL"], "spl_id": "3d6c971a-8ea9-cb50-e063-6394a90a4750", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313564"], "spl_set_id": ["5e39bf80-ada6-4194-bf3d-2c044c3389da"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (70518-4100-0)", "package_ndc": "70518-4100-0", "marketing_start_date": "20240612"}, {"sample": false, "description": "14 TABLET in 1 BOTTLE, PLASTIC (70518-4100-2)", "package_ndc": "70518-4100-2", "marketing_start_date": "20240612"}, {"sample": false, "description": "7 TABLET in 1 BOTTLE, PLASTIC (70518-4100-3)", "package_ndc": "70518-4100-3", "marketing_start_date": "20240709"}, {"sample": false, "description": "4 TABLET in 1 BOTTLE, PLASTIC (70518-4100-4)", "package_ndc": "70518-4100-4", "marketing_start_date": "20240804"}, {"sample": false, "description": "10 TABLET in 1 BOTTLE, PLASTIC (70518-4100-5)", "package_ndc": "70518-4100-5", "marketing_start_date": "20250402"}, {"sample": false, "description": "20 TABLET in 1 BOTTLE, PLASTIC (70518-4100-6)", "package_ndc": "70518-4100-6", "marketing_start_date": "20250823"}], "brand_name": "Valacyclovir", "product_id": "70518-4100_3d6c971a-8ea9-cb50-e063-6394a90a4750", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "70518-4100", "generic_name": "Valacyclovir", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "1000 mg/1"}], "application_number": "ANDA209553", "marketing_category": "ANDA", "marketing_start_date": "20240612", "listing_expiration_date": "20261231"}